Evidence map›Paper›PMID 29088790›Full record

ArticleOncotarget2017

Tissue microarray staining reveals PLD1 and Sp1 have a collaborative, pro-tumoral effect in patients with osteosarcomas.

Xiao-Xu Wang, Ying Liao, Liang Hong, Zhi Zeng, Tang-Bo Yuan, Xue Xia, Jian Qin

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xiao-Xu WangDepartment of Orthopaedics, The Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, People's Republic of China.
Ying LiaoDepartment of Rehabilitation, The First Affiliated Hospital of Nanhua University, Hengyang, Hunan, People's Republic of China.
Liang HongDepartment of Orthopaedics, The Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, People's Republic of China.
Zhi ZengDepartment of Orthopaedics, The Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, People's Republic of China.
Tang-Bo YuanDepartment of Orthopaedics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Xue XiaDepartment of Orthopaedics, The Second Affiliated Hospital of Nanhua University, Hengyang, Hunan, People's Republic of China.
Jian QinDepartment of Orthopaedics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
University of South China · CNNanjing Medical University · CNFirst Affiliated Hospital of University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been reported that phospholipase D1 (PLD1) - a key enzyme involved in lipid metabolism - is important for the initiation and progression of various human solid cancers; however, its biological significance and regulation in human osteosarcomas remain elusive. In this study, We found that PLD1 and Specificity Protein 1 (Sp1) expression were elevated in 137 osteosarcoma specimens with immunohistochemical staining. Our results showed that both PLD1 and Sp1 were expressed at much higher rates in the cancerous tissue compared to adjacent normal tissue. A correlation analyze also indicated that PLD1 was significantly associated with lactate dehydrogenase expression (

Indexed as

immunohistochemistryosteosarcomaPLD1prognosisSp1

Identifiers

PMID29088790
PMCPMC5650345
OpenAlexW2752500703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.